NSE filing, NSE: UNIHEALTH. Summary written from the filing by ALFA Finder's alert engine.
Unihealth Hospitals Ltd: key numbers
- Share price
- ₹564.95
- Market cap
- ₹903.9 Cr
- Revenue (annual)
- ₹132.0 Cr
- Net profit (annual)
- ₹25.83 Cr
- P/E (TTM)
- 35.0×Sector 34.1×
- Promoter holding
- 64.82%
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Unihealth Hospitals Ltd
All →Unihealth Hospitals Annual General Meeting
Unihealth Hospitals reported postal ballot results: all three resolutions passed, covering a related-party loan-to-equity conversion with UMC Hospitals, variation of unutilised IPO proceeds, and migration from NSE Emerge to the main board. No rupee amount is stated for the approvals.
Unihealth Hospitals Business Update
Unihealth Hospitals provided free scoliosis surgeries to two underprivileged children at UMC Hospitals, Navi Mumbai with charitable foundations. No monetary value is stated.
Unihealth Hospitals Other Announcement
Unihealth Hospitals Limited has submitted an intimation regarding the non-applicability of the Corporate Governance compliance report due to its listing on the NSE SME platform.
Unihealth Hospitals Convertible Warrants
Unihealth Hospitals allotted 2,00,000 equity shares upon conversion of warrants at Rs. 151 per share, totaling Rs. 3.02 Crore.
- Value
- ₹3.02 Cr
Unihealth Hospitals Annual General Meeting
Unihealth Hospitals has issued a postal ballot notice seeking shareholder approval for a material related party transaction, IPO proceeds variation, and migration to the main board.
- Value
- ₹26.00 Cr
Unihealth Hospitals Annual General Meeting
UniHealth Hospitals Limited issued a Postal Ballot notice seeking shareholder approval for a related party transaction, IPO proceeds variation, and migration to the main board.
Other board meeting date announcements
All →RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.
Parag Milk Foods Board Meeting Date
Parag Milk Foods has notified BSE of a board meeting on 3 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closure runs from 1 October to 5 November 2026.
Vedant Fashions Board Meeting Date
Vedant Fashions will hold a board meeting on 5 November 2026 to consider unaudited results for the quarter and half-year ended September 2026. The meeting is a prior intimation, so no results are approved yet.
Dangee Dums Board Meeting Date
Dangee Dums will hold a board meeting on 2 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. Trading window closure runs until 4 November 2026.
Relic Technologies Board Meeting Date
Relic Technologies intimated a board meeting on 2 Nov 2026 to consider unaudited standalone and consolidated Q2 results for the period ended 30 Sep 2026. The trading window closes from 1 Oct 2026 until 48 hours after the results are disseminated.